Benitec Biopharma Inc. (BNTC) Form 10-K Annual Reports
Benitec Biopharma Inc. (BNTC) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BNTC
CIK: 1808898
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 06/30
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Baker Tilly US, LLP
Auditor SinceSince 6/30/2021 12:00:00 AM
Lead Engagement PartnerThomas Kenaya
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-05 | 2026-10-05 | 8-K | 0001193125-26-413177 | View SEC Doc Filr Page |
| 8-K | 2026-09-30 | 2026-09-29 | 8-K | 0001193125-26-409052 | View SEC Doc Filr Page |
| 8-K | 2026-09-24 | 2026-09-18 | 8-K | 0001193125-26-401110 | View SEC Doc Filr Page |
| EFFECT | 2026-09-21 | — | EFFECT Filing | 9999999995-26-003021 | View SEC Doc Filr Page |
| S-3 | 2026-09-14 | — | S-3 | 0001193125-26-390758 | View SEC Doc Filr Page |
| 10-K | 2026-09-14 | 2026-06-30 | 10-K | 0001193125-26-390570 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-14 | 8-K | 0001193125-26-390539 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-29 | 4 | 0001193125-26-290586 | View SEC Doc Filr Page |
| 8-K | 2026-05-29 | 2026-05-22 | 8-K | 0001193125-26-248289 | View SEC Doc Filr Page |
| 4 | 2026-05-28 | 2026-05-26 | 4 | 0001193125-26-245918 | View SEC Doc Filr Page |
| 3 | 2026-05-28 | 2026-05-22 | 3 | 0001193125-26-245915 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001193125-26-222885 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001193125-26-222879 | View SEC Doc Filr Page |
| UPLOAD | 2026-04-03 | — | UPLOAD Filing | 0000000000-26-003380 | View SEC Doc Filr Page |
| CORRESP | 2026-03-20 | — | CORRESP Filing | 0001193125-26-117627 | View SEC Doc Filr Page |
| 10-K/A | 2026-03-20 | 2025-06-30 | 10-K/A | 0001193125-26-117604 | View SEC Doc Filr Page |
| UPLOAD | 2026-02-24 | — | UPLOAD Filing | 0000000000-26-001911 | View SEC Doc Filr Page |
| 8-K | 2026-02-12 | 2026-02-12 | 8-K | 0001193125-26-047742 | View SEC Doc Filr Page |
| 10-Q | 2026-02-12 | 2025-12-31 | 10-Q | 0001193125-26-047737 | View SEC Doc Filr Page |
| 424B3 | 2026-02-11 | — | 424B3 | 0001193125-26-044984 | View SEC Doc Filr Page |
| EFFECT | 2026-02-10 | — | EFFECT Filing | 9999999995-26-000516 | View SEC Doc Filr Page |
| CORRESP | 2026-02-06 | — | CORRESP Filing | 0001193125-26-041308 | View SEC Doc Filr Page |
| UPLOAD | 2026-02-06 | — | UPLOAD Filing | 0000000000-26-001290 | View SEC Doc Filr Page |
| S-3 | 2026-01-30 | — | S-3 | 0001193125-26-031753 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-01-29 | — | SCHEDULE 13G/A Filing | 0000038777-26-000024 | View SEC Doc Filr Page |